|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/40 |
| (11) | Patento numeris | 3169709 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15739763.9 |
| Europos patento paraiškos padavimo data | 2015-07-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/040211 |
| Data | 2015-07-13 |
| (87) | Numeris | WO 2016/010924 |
| Data | 2016-01-21 |
| (30) | Numeris | Data | Šalis |
| 201462024399 P | 2014-07-14 | US |
| (72) |
TWINKLE, Christian R., US
CLOGSTON, Christi L., US
OSSLUND, Timothy David, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | CRYSTALLINE ANTIBODY FORMULATIONS |
| CRYSTALLINE ANTIBODY FORMULATIONS |